Key result
Iloprost attenuates doxorubicin-induced cardiac dysfunction and apoptosis exacerbated by COX-2 disruption in mice.
Why the study?
Does genetic disruption of COX-2 modulate doxorubicin-induced cardiac injury and dysfunction in mice?
Does genetic disruption of COX-2 modulate doxorubicin-induced cardiac injury and dysfunction in mice?
Genetic disruption of COX-2 exacerbates doxorubicin-induced cardiotoxicity in mice, suggesting a protective role for prostaglandins that can be partially restored by prostacyclin analogs.
Answers are grounded in this paper and cite their sources.
COX-2 disruption worsens doxorubicin cardiotoxicity in mice; leaves open whether prostaglandin pathways protect human hearts during chemotherapy.
To determine the role of cyclooxygenase (COX)-2 in anthracycline-induced cardiac toxicity, we administered doxorubicin (Dox) to mice with genetic disruption of COX-2 (COX-2-/-). After treatment with Dox, COX-2-/- mice had increased cardiac dysfunction and cardiac cell apoptosis compared with Dox-treated wild-type mice. The expression of the death-associated protein kinase-related apoptosis-inducing protein kinase-2 was also increased in Dox-treated COX-2-/- animals. The altered gene expression, cardiac injury, and dysfunction after Dox treatment in COX-2-/- mice was attenuated by a stable prostacyclin analog, iloprost. Wild-type mice treated with Dox developed cardiac fibrosis that was absent in COX-2-/- mice and unaffected by iloprost. These results suggest that genetic disruption of COX-2 increases the cardiac dysfunction after treatment with Dox by an increase in cardiac cell apoptosis. This Dox-induced cardiotoxicity in COX-2-/- mice was attenuated by a prostacyclin analog, suggesting a protective role for prostaglandins in this setting.
No takes yet. Share an insight, caveat, or question.
Neilan et al. (2006) studied Anthracycline-induced cardiac toxicity. Genetic disruption of COX-2 (COX-2-/-) vs. Wild-type mice was evaluated on Cardiac dysfunction and cardiac cell apoptosis. Genetic disruption of COX-2 in mice increased cardiac dysfunction and apoptosis after doxorubicin treatment, an effect that was attenuated by the prostacyclin analog iloprost.
Synapse has enriched 10 related papers. Consider them for comparative context: